Hughes Steven George
SEC insider (Form 3/4/5 filer). CIK 0001747528. Chief Medical Officer at Atrium Therapeutics, Inc. (RNA) and 1 other issuer. 29 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2026. Located in SAN DIEGO, CA.
Companies Hughes Steven George has filed insider reports for
- Atrium Therapeutics, Inc. (RNA): Officer, Chief Medical Officer
- Avidity Biosciences, Inc. (RNAM): Officer, Chief Medical Officer
Hughes Steven George
CIK: 0001747528
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Sep 18, 2026RNA
Atrium Therapeutics, Inc.
Tax PaymentDirect21.5K shares at avg. $8.95$192K - Apr 20, 2026RNA
Atrium Therapeutics, Inc.
AwardDirect30K shares- - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
DispositionDirect115.9K shares- - Jan 21, 2026RNA
Avidity Biosciences, Inc.
SaleDirect2K shares at avg. $72.45$146K - Jan 21, 2026RNA
Avidity Biosciences, Inc.
SaleDirect2.9K shares at avg. $72.45$209K - Jan 7, 2026RNA
Avidity Biosciences, Inc.
SaleDirect2.4K shares at avg. $72.23$171K - Oct 22, 2025RNA
Avidity Biosciences, Inc.
ExerciseDirect2.2K shares at avg. $10.16$22K - Oct 22, 2025RNA
Avidity Biosciences, Inc.
SaleDirect2.2K shares at avg. $47.54$105K - Sep 22, 2025RNA
Avidity Biosciences, Inc.
ExerciseDirect2.2K shares at avg. $10.16$22K - Sep 22, 2025RNA
Avidity Biosciences, Inc.
SaleDirect2.2K shares at avg. $40.58$90K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 18, 2026 |  RNA Atrium Therapeutics, Inc. | Tax Payment | 21,459 | $8.95 | $192,058 | Direct |
| Apr 20, 2026 | RNA Atrium Therapeutics, Inc. | Award | 30,000 | - | $0 | Direct |
| Feb 27, 2026 |  RNAM Avidity Biosciences, Inc. | Disposition | 115,857 | - | $0 | Direct |
| Jan 21, 2026 | RNA Avidity Biosciences, Inc. | Sale | 2,017 | $72.45 | $146,132 | Direct |
| Jan 21, 2026 | RNA Avidity Biosciences, Inc. | Sale | 2,878 | $72.45 | $208,511 | Direct |
| Jan 7, 2026 | RNA Avidity Biosciences, Inc. | Sale | 2,373 | $72.23 | $171,402 | Direct |
| Oct 22, 2025 | RNA Avidity Biosciences, Inc. | Exercise | 2,209 | $10.16 | $22,443 | Direct |
| Oct 22, 2025 | RNA Avidity Biosciences, Inc. | Sale | 2,209 | $47.54 | $105,015 | Direct |
| Sep 22, 2025 | RNA Avidity Biosciences, Inc. | Exercise | 2,208 | $10.16 | $22,433 | Direct |
| Sep 22, 2025 | RNA Avidity Biosciences, Inc. | Sale | 2,208 | $40.58 | $89,601 | Direct |
1-10 of 29 transactions